50 individually packed test strips for detection of microalbumin at a cut-off of 20 μg/mL urine, delivering a visual result
Inhalt:
50 test strips
1 package insert
Exclusively for professional users
Discover more than 2,000 medical and toxicological tests and POCT solutions
Please note: The prices shown are basic list prices. Your individual prices will be displayed after you have logged in to the shop. Your personal customer advisors can add them at any time.
The NADAL® Microalbumin Test is an immunochemical lateral flow test for the qualitative detection of microalbumin at a cut-off of 20 μg/mL urine, delivering a visual result. The product is intended for professional use only. The test delivers a preliminary analytic result. For confirmation of the test result another detection method is required. Clinical considerations and professional judgment should be used in the interpretation of each test result, particularly when preliminary positive results are indicated.
The persistent appearance of small increases in albumin excretion in urine (so-called microalbuminuria) could be the first sign of renal dysfunction in type 1 diabetes (= incipient diabetic nephropathy). Without appropriate therapeutic intervention, the complication will progress with a further increase in albumin excretion (= macroalbuminuria), resulting in renal insufficiency. In case of type-2 diabetes, the early diagnosis and therapy of diabetic nephropathy is especially important. In addition to the renal dysfunction, cardiovascular risks could occur. At normal physiological conditions, small amounts of albumin are glomerular filtrated and tubular reabsorbed. The expulsion of 20 μg/mL to 200 μg/mL is characterised as microalbuminuria. In addition to renal dysfunctions, albuminuria can be caused by physical training, infections of the urinary tract, hypertension, cardiac insufficiency and surgery. If the amount of albumin decreases after disappearance of these factors, the transient albuminuria is without any clinical significance.
